Bleeding Disorders Treatment Market

1
MarketsandMarkets Presents

• Bleeding Disorders Treatment Market
• Global Forecast to 2021

2

• The global bleeding disorders treatment market is
  expected to reach USD 15.09 Billion by 2021 from
  USD 10.33 Billion in 2016 at a CAGR of 7.9 from
  2016 to 2021. The major factors driving the
  market growth include the growing patient
  population base, RD activities, and increasing
  focus on recombinant products by pharmaceutical
  companies. Emerging markets offer significant
  growth opportunities for the market. On the other
  hand, high treatment cost for bleeding disorder
  treatment products coupled with limited
  reimbursement is expected to hinder the growth of
  this market during the forecast period.
• The global bleeding disorders treatment market is
  broadly classified by type and drug class. Based
  on type, the market is classified as hemophilia
  A, hemophilia B, vWD, and others. Hemophilia A is
  the largest segment and is projected to witness a
  healthy CAGR in forecast period.

3

• http//www.marketsandmarkets.com/Market-Reports/bl
  eeding-disorder-treatment-market-71198026.html
• The growing number of patients suffering from
  hemophilia A, coupled with increasing awareness,
  and increasing RD activities for development of
  novel products for treating hemophilia A by major
  pharmaceuticals are key drivers for this market
  segment. Based on drug class, the bleeding
  disorders treatment market is segmented into
  plasma-derived coagulation factor concentrates,
  recombinant coagulation factor concentrates,
  desmopressin, antifibrinolytics, fibrin sealants,
  and others. 

4

• The recombinant coagulation factor concentrates
  segment is expected to witness the highest growth
  rate during the forecast period. This increasing
  focus on developing recombinant factors due to
  their high efficiency in preventing bleeding
  episodes over plasma-derived products are driving
  their market demand.
• The global bleeding disorders treatment market is
  dominated by North America, followed by Europe.
  North America will continue to dominate the
  global market in the forecast period. The high
  acceptance for prophylaxis treatment among all
  age groups in the U.S. is a key market driver in
  the region.
• The key players in the bleeding disorders
  treatment market are are Shire Plc. (earlier
  Baxalta) (Ireland), Bayer AG (Germany), Biogen
  Inc. (U.S.), CSL Behring (U.S.), Novo Nordisk
  (Denmark), Pfizer Inc. (U.S.), and Grifols SA
  (Spain).

5
Contact Us

• Mr. RohanMarkets and Markets UNIT no 802, Tower
  no. 7, SEZMagarpatta city, HadapsarPune,
  Maharashtra 411013, India1-888-600-6441Email
  sales_at_marketsandmarkets.com
• MarketsandMarkets Blog
• http//www.linkedin.com/company/marketsandmarkets
• http//twitter.com/marketsmarkets

6
About MarketsandMarkets
MarketsandMarkets is a global market research and
consulting company based in the U.S. We publish
strategically analyzed market research reports
and serve as a business intelligence partner to
Fortune 500 companies across the
world. MarketsandMarkets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotives and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at
MarketsandMarkets are inspired to help our
clients grow by providing apt business insight
with our huge market intelligence repository.